Clinical impact of splicing in neurodevelopmental disorders

被引：16
|
作者：
Sanders, Stephan J. [1 ,2 ]
Schwartz, Grace B. [1 ,2 ]
Farh, Kyle Kai-How [3 ]
机构：
[1] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94158 USA
[3] Illumina Inc, Illumina Artificial Intelligence Lab, San Diego, CA USA
来源：
GENOME MEDICINE | 2020年 / 12卷 / 01期
关键词：
Gene splicing; Isoform; SpliceAI; Autism spectrum disorder; Developmental delay; Clinical exome sequencing; Cryptic splice site; Canonical splice site; Polypyrimidine tract; Antisense oligonucleotide;
D O I：
10.1186/s13073-020-00737-2
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Clinical exome sequencing is frequently used to identify gene-disrupting variants in individuals with neurodevelopmental disorders. While splice-disrupting variants are known to contribute to these disorders, clinical interpretation of cryptic splice variants outside of the canonical splice site has been challenging. Here, we discuss papers that improve such detection.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Clinical impact of splicing in neurodevelopmental disorders
    Stephan J. Sanders
    Grace B. Schwartz
    Kyle Kai-How Farh
    Genome Medicine, 12
  • [2] Impact of clinical exomes in neurodevelopmental and neurometabolic disorders
    Evers, Christina
    Staufner, Christian
    Granzow, Martin
    Paramasivam, Nagarajan
    Hinderhofer, Katrin
    Kaufmann, Lilian
    Fischer, Christine
    Thiel, Christian
    Opladen, Thomas
    Kotzaeridou, Urania
    Wiemann, Stefan
    Schlesner, Matthias
    Eils, Roland
    Koelker, Stefan
    Bartram, Claus R.
    Hoffmann, Georg F.
    Moog, Ute
    MOLECULAR GENETICS AND METABOLISM, 2017, 121 (04) : 297 - 307
  • [3] The clinical significance of poisoned splicing variants in early-onset neurodevelopmental disorders
    Felker, Stephanie
    Lawlor, James
    Latner, Donald
    Thompson, Michelle
    Bowling, Kevin
    Hiatt, Susan
    Finnila, Candice
    Cooper, Gregory
    GENETICS IN MEDICINE, 2022, 24 (03) : S76 - S77
  • [4] Impact of the Olig Family on Neurodevelopmental Disorders
    Szu, Jenny
    Wojcinski, Alexandre
    Jiang, Peng
    Kesari, Santosh
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [5] Clinical interpretation of aCGH results in patients with neurodevelopmental disorders by geneticists: impact on diagnostic yield
    Olivucci, Giulia
    Severi, Giulia
    Visconti, Paola
    Posar, Annio
    Scaduto, Maria Cristina
    Graziano, Claudio
    Seri, Marco
    Magini, Pamela
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 459 - 459
  • [6] The impact of the environment on neurodevelopmental disorders in early childhood
    de Araujo Scattolin, Monica Ayres
    Resegue, Rosa Miranda
    do Rosario, Maria Conceicao
    JORNAL DE PEDIATRIA, 2022, 98 : S66 - S72
  • [7] Screening for substance use disorders in neurodevelopmental disorders: a clinical routine?
    Palmqvist, Margita
    Edman, Gunnar
    Bolte, Sven
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2014, 23 (05) : 365 - 368
  • [8] Screening for substance use disorders in neurodevelopmental disorders: a clinical routine?
    Margita Palmqvist
    Gunnar Edman
    Sven Bölte
    European Child & Adolescent Psychiatry, 2014, 23 : 365 - 368
  • [9] Clinical trials for neurodevelopmental disorders: At a therapeutic frontier
    Jeste, Shafali S.
    Geschwind, Daniel H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (321)
  • [10] Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders
    Porter, Robert S.
    Jaamour, Farris
    Iwase, Shigeki
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2018, 87 : 35 - 45
12345